These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sarilumab (Kevzara) for rheumatoid arthritis. Med Lett Drugs Ther; 2017 Aug; 59(1527):134-136. PubMed ID: 28787744 [No Abstract] [Full Text] [Related]
8. New therapeutic options in rheumatoid arthritis: a focus on interleukin-6 blockade. Furfaro N J Infus Nurs; 2011; 34(2):107-15. PubMed ID: 21399456 [TBL] [Abstract][Full Text] [Related]
9. Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy. Nishina N; Kikuchi J; Hashizume M; Yoshimoto K; Kameda H; Takeuchi T Ann Rheum Dis; 2014 May; 73(5):945-7. PubMed ID: 24336338 [No Abstract] [Full Text] [Related]
10. IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions. Woodrick RS; Ruderman EM Bull NYU Hosp Jt Dis; 2012; 70(3):195-9. PubMed ID: 23259628 [TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis: IL-6 inhibition in RA--déjà vu all over again? Ruderman EM Nat Rev Rheumatol; 2015 Jun; 11(6):321-2. PubMed ID: 25907702 [No Abstract] [Full Text] [Related]
19. Polyarticular late infection of total joint arthroplasties in a patient with rheumatoid arthritis treated with anti-interleukin-6 therapy. Wakabayashi H; Takigawa S; Hasegawa M; Kakimoto T; Yoshida K; Sudo A Rheumatology (Oxford); 2014 Jun; 53(6):1150-1. PubMed ID: 24273024 [No Abstract] [Full Text] [Related]
20. Interleukin 6 as therapeutic target in athero-/arteriosclerosis--small steps towards a new treatment paradigm in cardiovascular disease? Henry RM Atherosclerosis; 2011 Dec; 219(2):390-1. PubMed ID: 21840523 [No Abstract] [Full Text] [Related] [Next] [New Search]